The Hong Kong Polytechnic University recently found bacteria that carries the colistin resistance gene mcr-1commonly exists in human and various types of food and environmental samples collected [...]
The ongoing MRSA epidemic is a global public health crisis and Methicillin-resistant Staphyloccocus aureus, MRSA, is rampant in U.S. healthcare facilities and in the community. Read More.
This is a great mention in the News & Observer speaking about the war against superbugs starting in North Carolina. Trana Discovery supports proper prescribing and use of antibiotics when [...]
This is the first case reported of a healthy individual who carried a Salmonella sp.bacteria that carried the mcr-1 plasmid. This variant confers resistance to colistin and reminds us of the [...]
For your blog, bacteria carrying the plasmid that confers resistance to colistin continues to spread. The CDC has generated a map showing where the mcr-1 gene has been reported in the United [...]
The group of researchers who initially identified the mcr-1 gene in China have followed up with a study of clinical isolates from two provinces finding the gene is spreading across other species [...]
Joint research efforts could lead to new solutions against plant diseases affecting World’s food supply CARY, NC (January 23, 2017) – Trana Discovery, Inc., Cary, North Carolina, USA today [...]
The Associated Press is reporting an outbreak of infections due to the superbug Carbapenem-Resistant Enterobacteriaceae, or CRE, at the Ronald Reagan UCLA Medical Center. At least seven patients [...]
The Associated Press is reporting an outbreak of infections due to the superbug Carbapenem-Resistant Enterobacteriaceae, or CRE, at the Ronald Reagan UCLA Medical Center. At least seven patients [...]
Trana Discovery provides a proprietary drug discovery technology platform that enables its partners to discover new treatments of bacterial, viral, and fungal infectious diseases.
919-295-6116
info@tranadiscovery.com
